Emergent Biosolutions
Price & Volume
Stats
See more52W Range | $4.36-$14.06 |
Market Cap | $304.5M |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $770.2M |
Revenue Growth (YoY) | 66.3% |
Gross Profit (12 Mos) | $380.4M |
Diluted EPS | -$3.41 |
News
See moreYahoo Finance • 14 days ago
Catalyst Watch: Eyes on Walmart, Alibaba, Reddit, and McDonald's energy drink push
Yahoo Finance • 16 days ago
Emergent BioSolutions (EBS) Q2 2026 Earnings Call Transcript
Yahoo Finance • 21 days ago
Endometrial Cancer Market Share Analysis and Industry Trends (2026-2031) Featuring Merck, Eisai, Karyopharm Therapeutics, Context Therapeutics, Seagen and More
Yahoo Finance • 3 months ago
Emergent BioSolutions to Participate in Upcoming Investor Conferences
About
CEO | Mr. Joseph C. Papa Jr., M.B.A., R.Ph. |
CFO | Mr. Richard S. Lindahl M.B.A. |
Address | 300 Professional Drive, Gaithersburg, MD, United States, 20879 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 900 |